Home » Newsletters » BioWorld Science

BioWorld Science

April 21, 1998

View Archived Issues

Mechanisms mediating the effects of ADM on cardiac contractility

Neurotropin, a therapeutic agent for PGE1 therapy-associated penile pain

SmithKline Beecham provides update on product pipeline and future directions

Company Profile: Myelos Neurosciences

Unexpected results from a study of gene therapy for rheumatoid arthritis

mRNA splicing appears to trigger metastasis in prostate cancer

Collaborations formed to further development of memantine

ImmuLogic evaluates cocaine vaccine in phase I

Sheffield signs option agreement with Zambon for MSI delivery system

Shire to market Fidia's new osteoarthritis treatment

Cypros receives notice of allowance on patent claiming Cordox for asthma

New data reported for donepezil hydrochloride

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

Synthelabo discloses new benzimidazoles for urinary incontinence

New antiparasitic compounds from Kitasato Institute

Tobishi synthesizes new CCK-A antagonist for treatment of pancreatitis

MS&D discovers agents for safely enhancing cognition

Novel ACAT inhibitor presented at Japanese congress

Dainippon presents a BZP inverse agonist for the treatment of dementia

Heterocyclic tachykinin antagonists from Sanofi

Phase I data reported for antitumor bisnaphthalimide DMP-840

New water-soluble dolastatin derivatives with potent antitumor activity

Atlantic's 2-5A antisense compound shows excellent anti-RSV activity in vitro

Sanofi discloses cGMP PDE inhibitors for cardiovascular indications

Orphan drug designation granted for Xerecept

Trega initiates phase I testing of HP-228 using novel pulmonary delivery system

More retinoids emerge from the Allergan pipeline

Amarillo Biosciences receives notice of allowance for U.S. patent

Repligen receives Phase II SBIR grant for angiogenesis research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.